+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice



Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice



Proceedings of the National Academy of Sciences of the United States of America 99(13): 8968-8973



Mutations in alpha-synuclein (alpha-Syn) cause Parkinson's disease (PD) in a small number of pedigrees with familial PD. Moreover, alpha-Syn accumulates as a major component of Lewy bodies and Lewy neurites, intraneuronal inclusions that are neuropathological hallmarks of PD. To better understand the pathogenic relationship between alterations in the biology of alpha-Syn and PD-associated neurodegeneration, we generated multiple lines of transgenic mice expressing high levels of either wild-type or familial PD-linked Ala-30 --> Pro (A30P) or Ala-53 --> Thr (A53T) human alpha-Syns. The mice expressing the A53T human alpha-Syn, but not wild-type or the A30P variants, develop adult-onset neurodegenerative disease with a progressive motoric dysfunction leading to death. Pathologically, affected mice exhibit neuronal abnormalities (in perikarya and neurites) including pathological accumulations of alpha-Syn and ubiquitin. Consistent with abnormal neuronal accumulation of alpha-Syn, brain regions with pathology exhibit increases in detergent-insoluble alpha-Syn and alpha-Syn aggregates. Our results demonstrate that the A53T mutant alpha-Syn causes significantly greater in vivo neurotoxicity as compared with other alpha-Syn variants. Further, alpha-Syn-dependent neurodegeneration is associated with abnormal accumulation of detergent-insoluble alpha-Syn.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046286594

Download citation: RISBibTeXText

PMID: 12084935

DOI: 10.1073/pnas.132197599


Related references

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 fwdarw Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 99(13): 8968-8973, June 25, 2002

Human a-synculein-harboring familial Parkinson's disease-linked Ala-53 - > Thr mutation causes neurodegenerative disease with a-synuclein aggregation in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 99(13): 68-73, 2002

HUMAN alpha - SYNUCLEIN HARBORING ALA53THR MUTATION CAUSES NEURODENERATIVE DISEASE WITH alpha - SYNUCLEIN AGGREGATION IN TRANSGENIC MICE. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 118 10, 2002

Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants. Biochemical and Biophysical Research Communications 386(1): 165-169, 2009

Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation. Experimental Neurology 187(2): 279-288, 2004

Alpha-synuclein and Parkinson's disease: selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo. Annals of Neurology 47(5): 632-640, 2000

Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice. Acta Neuropathologica 120(2): 145-154, 2010

Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation. Journal of Neuroscience 24(33): 7400-7409, 2004

A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. Journal of Biological Chemistry 280(24): 22670-8, 2005

Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease. Behavioural Brain Research 339: 153-168, 2017

Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proceedings of the National Academy of Sciences of the United States of America 102(6): 2162-2167, 2005

Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression. Molecular and Cellular Neurosciences 49(2): 230-239, 2012

Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease. Neurobiology of Disease 18(3): 492-498, 2005

Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations. Journal of Neurochemistry 88(2): 401-410, 2003

Overexpression of wild type and familial Parkinsons disease linked mutant human alpha-synuclein in transgenic mouse. Society for Neuroscience Abstracts 25(1-2): 49, 1999